PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma
- PMID: 34872754
- DOI: 10.1016/j.pathol.2021.09.013
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma
Abstract
Cancer immunomodulation has been implicated in the development of oral squamous cell carcinoma (OSCC), however the role of specific immunomodulatory proteins is not completely understood, particularly in the early stages of the disease. Oral potentially malignant disorders such as leukoplakia commonly precede OSCC but not all will undergo malignant transformation. The aim of this study was to evaluate the diagnostic utility of specific immunomodulator proteins and their role in the progression of OSCC. Samples from 101 patients were included in the study. Cases were classified based on histopathology into four groups: non-dysplastic epithelial hyperplasia/keratosis, low-grade dysplasia, high-grade dysplasia, and OSCC. The PD-1/PD-L1 pathway, as well as regulatory T cell (Treg)-related proteins including FOXP3, TGF-β, IL-6, and IL-10 were immunohistochemically quantified. The number of tumour-infiltrating lymphocytes (TILs) was also assessed for each case. Multinominal regression models were undertaken to assess the significance of each protein in predicting the histopathological grade of oral epithelial disorders, and three diagnostic models were assessed. Significant positive associations were found between the immunoreactive score of each protein and the histopathological grade, p<0.05 suggesting that the PD-1/PD-L1 pathway, Treg-related proteins, and TILs are associated with the development of OSCC. Diagnostic models using the investigated proteins and TILs predicted the grade of oral epithelial disorder, p<0.05. The associated accuracy of this approach was 84.92%. Our findings support the notion that immunomodulation events may play a role in evading the immune system and contributing to potential malignant transformation of oral epithelial disorders. Our data also provide supporting evidence for the potential application of immune checkpoint inhibitors in the chemoprevention of OSCC. Further longitudinal studies to assess individual T-cell populations within the immune microenvironment of various oral potentially malignant disorders are warranted.
Keywords: Tumour-infiltrating lymphocytes; immunomodulatory; oral carcinogenesis; oral epithelial dysplasia; squamous cell carcinoma.
Copyright © 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.Sci Rep. 2023 Dec 7;13(1):21698. doi: 10.1038/s41598-023-48572-w. Sci Rep. 2023. PMID: 38066025 Free PMC article.
-
Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.Pathol Res Pract. 2019 Jun;215(6):152418. doi: 10.1016/j.prp.2019.04.010. Epub 2019 Apr 18. Pathol Res Pract. 2019. PMID: 31027907
-
Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.Oral Dis. 2023 Nov;29(8):3268-3277. doi: 10.1111/odi.14332. Epub 2022 Aug 25. Oral Dis. 2023. PMID: 35921211
-
ICI-based therapies: A new strategy for oral potentially malignant disorders.Oral Oncol. 2023 May;140:106388. doi: 10.1016/j.oraloncology.2023.106388. Epub 2023 Apr 11. Oral Oncol. 2023. PMID: 37054586 Review.
-
Tumor-infiltrating ICOS+ Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor.Anticancer Res. 2022 May;42(5):2383-2393. doi: 10.21873/anticanres.15717. Anticancer Res. 2022. PMID: 35489733 Review.
Cited by
-
Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.Front Immunol. 2022 Sep 2;13:954567. doi: 10.3389/fimmu.2022.954567. eCollection 2022. Front Immunol. 2022. PMID: 36119104 Free PMC article.
-
Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.Biomedicines. 2024 Mar 5;12(3):577. doi: 10.3390/biomedicines12030577. Biomedicines. 2024. PMID: 38540190 Free PMC article. Review.
-
The Immune Cells in the Development of Oral Squamous Cell Carcinoma.Cancers (Basel). 2023 Jul 26;15(15):3779. doi: 10.3390/cancers15153779. Cancers (Basel). 2023. PMID: 37568595 Free PMC article. Review.
-
Precancerous Lesions of the Head and Neck Region and Their Stromal Aberrations: Piecemeal Data.Cancers (Basel). 2023 Apr 7;15(8):2192. doi: 10.3390/cancers15082192. Cancers (Basel). 2023. PMID: 37190121 Free PMC article. Review.
-
Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.Front Immunol. 2022 Jan 27;13:840923. doi: 10.3389/fimmu.2022.840923. eCollection 2022. Front Immunol. 2022. PMID: 35154165 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials